Skip to main content

Childs John W's Form 4/A amendment

Amended

Veradermics, Inc (MANE) · filed Feb 27, 2026

Accession no.
0001027035-26-000004
Filed
Feb 27, 2026
Trade date
Feb 5, 2026
Filing delay
22 days
Rule 10b5-1 plan
Not checked
Original filed
Feb 5, 2026

This filing lists 1 non-derivative transaction. It carries over 7 transactions from the original filing that it did not restate. Open-market purchases total $5.00M. It was filed 22 days after the trade.

This amendment restates part of 0001628280-26-005906 (filed Feb 5, 2026). The transactions it did not restate still count and are listed below.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Childs John WCIK 0001027035Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Feb 5, 2026Common StockPPurchaseAcquired+294,117$17.00+$4,999,989294,117Indirect

Carried over from the original filing

This amendment restates only part of the original filing. The original's other transactions still stand, and the trade tables on Livermore count them under this amendment.

From 0001628280-26-005906 (filed Feb 5, 2026).

Non-derivative securities (Table I)

Non-derivative transactions carried over from 0001628280-26-005906
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Feb 5, 2026Common StockCConversionAcquired+480,269––480,269Indirect
Feb 5, 2026Common StockCConversionAcquired+906,862––1,387,131Indirect
Feb 5, 2026Common StockCConversionAcquired+520,758––1,907,889Indirect

Derivative securities (Table II)

Derivative transactions carried over from 0001628280-26-005906
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Feb 5, 2026Common StockCConversionDisposed−480,269––0Indirect
Feb 5, 2026Common StockCConversionDisposed−906,862––0Indirect
Feb 5, 2026Common StockCConversionDisposed−520,758––0Indirect
Feb 3, 2026Common StockAGrant or awardAcquired+51,525$0.00$051,525Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)